The common painkiller acetaminophen was found to alter proteins in the heart tissue when used regularly at moderate doses, according to a new study conducted
Fresh off closing its $14 billion acquisition of Karuna Therapeutics a few weeks ago, Bristol Myers Squibb is presenting long-term data for its new subsidiary’s
The FDA has expanded the label for Johnson & Johnson and Legend Biotech’s multiple myeloma CAR-T therapy to make it a much earlier treatment option
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit
Share this article Imfinzi is approved in the US, EU, Japan, China, and other countries for the treatment of extensive-stage SCLC (ES-SCLC) based on results
The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted
TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange,
Faustinella and Auerbach are internists. Gajewski is a medical student who will soon start residency in internal medicine. As the Texas House and Senate decide
A single round of prostate cancer screening that included a prostate-specific antigen (PSA) test, a kallikrein panel, and an MRI detected one additional high-grade cancer